Aclaris Therapeutics ACRS
NASDAQ ACRS
$4.41 -0.85 (-16.16%)
At close: Oct 1, 2026 · 4:00 PM EDT

Aclaris Therapeutics (ACRS) Goodwill impairment charges (2019)

Updated

Aclaris Therapeutics' Goodwill impairment charges was $18.5 million in FY2019.

Analysis

Aclaris Therapeutics (ACRS) Goodwill impairment charges (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Aclaris Therapeutics 735.48 Mn 735.48 Mn 1.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 18.50 Mn
API Access

Aclaris Therapeutics Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=ACRS&period=max&api_key=YOUR_API_KEY